To commend the DEA's initiative to temporarily schedule certain kratom-related substances due to public safety concerns.
Approach:
DEA Notices of Intent: The DEA issued two Notices of Intent to temporarily schedule 7-OH and three synthetic derivatives (MP, MGM-15, MGM-16) in Schedule I.
Request for Information: The Office of the Assistant Secretary for Health (OASH) requested public comments on the proposed threshold level for 7-OH.
Key Findings:
7-OH and its synthetic derivatives are considered dangerous opioids that contribute to addiction.
The actions do not intend to regulate natural kratom leaf that contains trace amounts of 7-OH.
MP, MGM-15, and MGM-16 are synthetic derivatives that do not occur naturally in the kratom plant.
MP is a chemical rearrangement product of 7-OH, while MGM-15 and MGM-16 are synthetic derivatives of 7-OH.
Interpretation:
The scheduling of these substances aims to address the growing threat they pose to public health and safety.
Limitations:
The temporary scheduling order is subject to public comment and further review by the Attorney General.
Conclusion:
The initiative is part of a broader effort to combat the opioid epidemic and protect public health.
